Healthcare Equipment and Supplies
Company Overview of 20/20 GeneSystems, Inc.
20/20 GeneSystems, Inc. develops and commercializes diagnostics tests that help in the fight against cancer. The company provides proteomics products that provide tools for protein analysis; PredicTOR, a diagnostic test to predict the efficacy of molecularly-targeted therapies for the treatment of cancer; PAULAs, which provides blood test for the early detection of lung cancer; BioCheck, a suspicious powder screening test; and tumor response tests. It offers multiplex immunohistochemistry platform (L-IHC), which allows drug developers and other researchers to simultaneous detection of 10+ biomarkers in a single tissue section; and multiplexed analysis of protein markers in tissue solutions. ...
9430 Key West Avenue
Rockville, MD 20850
Founded in 2000
Key Executives for 20/20 GeneSystems, Inc.
Chief Executive Officer and President
Chief Operating Officer and Senior Vice President
Director of Research and Development
Vice President of Personalized Medicine
Compensation as of Fiscal Year 2014.
20/20 GeneSystems, Inc. Key Developments
20/20 GeneSystems, Inc. Presents at 2013 BIO Convention in China, Nov-11-2013
Nov 11 13
20/20 GeneSystems, Inc. Presents at 2013 BIO Convention in China, Nov-11-2013 . Venue: China National Convention Center, No.7 Tianchen East Road, Chaoyang District, Beijing 100105, China.
20/20 GeneSystems, Inc. Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013
May 21 13
20/20 GeneSystems, Inc. Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013 . Venue: Shangri-La Hotel, 29 Zizhuyuan Road, Beijing 100089, China.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries